According to Stratview Research, the spinal muscular atrophy medicine market was estimated at USD 1.26 billion in 2022 and is likely to grow at a CAGR of 13.44% during 2023-2028 to reach USD 2.68 billion in 2028. For individuals and families affected by spinal muscular atrophy (SMA), the quest for effective treatments and therapies has been long and...